Immunotech Biopharm (HKSE:06978) FCF Yield % : -13.41 (As of Jun. 05, 2024)

View and export this data going back to 2020. Start your Free Trial

What is Immunotech Biopharm FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Immunotech Biopharm's Trailing 12-Month Free Cash Flow is HK$-203.63 Mil, and Market Cap is HK$1,518.02 Mil. Therefore, Immunotech Biopharm's FCF Yield % for today is -13.41%.

The historical rank and industry rank for Immunotech Biopharm's FCF Yield % or its related term are showing as below:

HKSE:06978' s FCF Yield % Range Over the Past 10 Years
Min: -15.56 Med: 0 Max: 0
Current: -13.41

HKSE:06978's FCF Yield % is ranked better than
51.58% of 1553 companies
in the Biotechnology industry
Industry Median: -14.22 vs HKSE:06978: -13.41

Immunotech Biopharm's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

Immunotech Biopharm FCF Yield % Historical Data

The historical data trend for Immunotech Biopharm's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immunotech Biopharm FCF Yield % Chart

Immunotech Biopharm Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

Get a 7-Day Free Trial

-7.06

-6.16

-13.01

-7.91

Immunotech Biopharm Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Yield %	Get a 7-Day Free Trial						-5.82	-14.24	-10.39	-9.36	-7.11

Competitive Comparison of Immunotech Biopharm's FCF Yield %

For the Biotechnology subindustry, Immunotech Biopharm's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Immunotech Biopharm's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Immunotech Biopharm's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Immunotech Biopharm's FCF Yield % falls into.

Immunotech Biopharm FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Immunotech Biopharm's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-203.627	/	2572.92
	=	-7.91%

Immunotech Biopharm's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-91.435	*	2	/	2572.92
	=	-7.11%

Immunotech Biopharm FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Immunotech Biopharm FCF Yield % Related Terms

Thank you for viewing the detailed overview of Immunotech Biopharm's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Immunotech Biopharm (HKSE:06978) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immunotech Biopharm Ltd (HKSE:06978) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.1 Kangding Street, 8th Floor, Block 1, Guosheng Technology Park, Beijing Economic-technological Development Area, Beijing, CHN, 100176

Website

http://www.eaal.net

Immunotech Biopharm Ltd is a cellular immunotherapy biopharmaceutical company in China. The company is focused on the research, development, and commercialization of T-cell immunotherapy. Its product EAL is a multi-target cellular immunotherapy product for the treatment of various types of cancer. Its product pipeline features classes of cellular immunotherapy products, including both non-genetically modified and genetically modified products, as well as both multi-target and single-target products. Its other products include the CAR-T cell series and the TCR-T cell series.

Executives

Jung Hyun Chul
Evodevo Ltd
Tian Jin He Yue Ke Ji Fa Zhan He Huo Qi Ye You Xian He Huo	2501 Other
Wu Naifeng	2501 Other
Yan Kaijing	2501 Other
Yan Xijun	2501 Other
Tian Shi Li Kong Gu Ji Tuan You Xian Gong Si	2501 Other
Tian Shi Li Yi Yao Ji Tuan Gu Fen You Xian Gong Si	2501 Other
Tian Jin Di Zhi Tou Zi Guan Li You Xian Gong Si	2501 Other
Tian Jin Fu Hua De Ke Ji Kai Fa You Xian Gong Si	2501 Other
Li Yunhui	2501 Other
Tian Jin Hong Xun Ke Ji Fa Zhan He Huo Qi Ye You Xian He Huo	2501 Other
Tian Jin Kang Shun Ke Ji Fa Zhan He Huo Qi Ye You Xian He Huo	2501 Other
Tian Jin Shan Zhen Ke Ji Fa Zhan He Huo Qi Ye You Xian He Huo	2501 Other
Tian Jin Shun Qi Ke Ji Fa Zhan He Huo Qi Ye You Xian He Huo	2501 Other

Immunotech Biopharm (HKSE:06978) Headlines

No Headlines